Skip to content

Clinical trials

Phase 3 Asthma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 3 Country / region: China Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20103
20124
20141
20153
20176
20182
20193
20213
20221
20233
20246
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting11
Terminated4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca12
GlaxoSmithKline10
Novartis Pharmaceuticals5
Areteia Therapeutics2
Boehringer Ingelheim2
Chiesi Farmaceutici S.p.A.2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Guangdong Hengrui Pharmaceutical Co., Ltd1
Lunan Better Pharmaceutical Co., LTD.1
Mundipharma (China) Pharmaceutical Co. Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma45
Dyspnea2
Pulmonary Eosinophilia2
Bronchial Diseases1
Disease1
Hypersensitivity1
Lung Diseases1
Lung Diseases, Obstructive1
Lymphoma, Follicular1
Nasal Polyps1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.